Clinical Trials Logo

Clinical Trial Summary

Premature rupture of membranes (PROM) at term is a rupture that occurs at term (> 37 weeks) before the start of labor. The purpose of the study was to compare the safety and efficacy of two agents used in induction of labor in women with term PROM Propess (Controlled release dinoprostone, Vaginal Delivery System) and Prostin E2 (Dinoprostone vaginal Tablet). Women will be randomised to two treatment groups. Although some studies support efficacy of the Propess for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with PROM at term.


Clinical Trial Description

The study is going to include all pregnant women with in-term PROM (after week 37 of pregnancy) without contractions if they meet the inclusion criteria. If the cervix is still non-inducible after 4-6 hours and there are no contractions, the medication to be administered to them will be determined by means of computer randomization. The success rate of induction with Propess vs. Prostin tablets will be compared. Soon after PROM, there can be the onset of contractions and cervix dilation that lead to childbirth. In case of some pregnant women, there are no contractions and cervix dilation even after the event despite PROM and water breaking. If the status remains unchanged, the risk of intrauterine infection, fetus infection, and later on an infection of the newborn increases. The expecting mother can also eventually lose hope for a successful vaginal birth and starts thinking about having a caesarean delivery. To avoid that, the investigators use medications that accelerate the onset of vaginal birth in clinical practice. The investigators know several ways to induce labour after PROM. References give no clear and reliable data on the best approach. The investigators can use medications such as oxytocin, dinoprostone, or misoprostol. Our ward has been using Prostin 3 mg (dinoprostone) vaginal tablets to induce labour in case of PROM for several years. They have proven to be an efficient and safe procedure in our clinical practice. Propess is used for the induction of labor with intact membranes. Based on the information from references and according to our experience, the medication is highly effective and safe, as well as easy to use. Our study aims at establishing whether it can also be used with pregnant women with PROM. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04743297
Study type Interventional
Source University Medical Centre Maribor
Contact Veronika Anzeljc
Phone + 386 2 321 21 73
Email veronika.anzeljc@ukc-mb.si
Status Not yet recruiting
Phase Phase 4
Start date March 2021
Completion date January 2023

See also
  Status Clinical Trial Phase
Completed NCT02242214 - REgistry of MisOprostol 200 µg Vaginal dElivery System N/A
Recruiting NCT04163744 - Effectiveness and Safety of Induction of Labour Using a Double Balloon Catheter (INDOBA)
Terminated NCT02932319 - Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy N/A
Not yet recruiting NCT04887493 - To Study the Efficacy and Safety of Misoprostol by Sublingual Routes for Induction of Labour N/A
Completed NCT04454346 - Double Foley Catheter For Cervical Ripening N/A
Completed NCT00299754 - Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study) Phase 3
Completed NCT04477226 - Transvaginal Ultrasound As Predictors of Successful Induction of Labour
Completed NCT03355040 - Induction of Labour for LGA fœtus in Women Without Insulin-treated Diabetes.
Completed NCT03489928 - Misoprostol Labour Induction Study Phase 3